ERBB2 and central nervous system cancer: For example, the penetration of [14C]-carboplatin and anti-HER2 monoclonal antibody into the tumor volume was significantly increased by co-administration of KCa channel agonist, NS1619, to glioma-bearing Wistar rats via intracarotid infusion, leading to an enhanced survival [61].